What is RMD's forecasted revenue?

Resmed Inc. is forecasted to generate $5.77B in FY revenue, representing +8.1% year-over-year growth.

How accurate is the RMD revenue forecast model?

The ARDL model achieves 513.8% MAPE (Mean Absolute Percentage Error). In a holdout test, it predicted $1.3B versus the actual $1.4B.

Resmed Inc. RMD

Revenue Intelligence Report • 50 quarters of SEC filing data • Updated 2026-03-15

Resmed Inc. has a forecasted full-year revenue of $5.8B, a +8.1% year-over-year change, based on 50 quarters of SEC filing data. Key revenue drivers include R&D ($19.66 per $1) and SG&A ($6.94 per $1). The ARDL model has 513.8% MAPE.

Investment Thesis

At 513.8% MAPE, the model captures Resmed Inc.'s broad revenue trajectory, though quarterly variability suggests sensitivity to external factors. Every $1 of R&D investment is associated with $19.66 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $6.94 in revenue, reflecting strong commercial efficiency.

Next FY Revenue

$5.77B

+8.1% YoY

R&D Multiplier

$19.66 per $1

SG&A Multiplier

$6.94 per $1

Model Accuracy

513.8% MAPE

Holdout validation: The model predicted $1.3B vs the actual $1.4B — an error of 6.0%.

Revenue Forecast

Quarterly Detail

Quarter	Model Forecast	Actual	95% Range	YoY Growth	Status
Q4 2025	$1.3B	$1.4B	$1.2B – $1.5B	+9.2%	✓ In range
Q2 2026	$1.4B		$1.2B – $1.6B	+9.6%
Q3 2026	$1.4B		$1.2B – $1.7B	+10.3%
Q4 2026	$1.5B		$1.1B – $1.8B	+9.1%
Q1 2027	$1.5B		$1.1B – $1.8B	+4.0%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Resmed Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.

Fiscal Quarter	Seasonal Factor	vs Trend	Interpretation	Obs.
FQ1 (Sep–Nov)	1.0086	+0.9%	In line with trend	15
FQ2 (Dec–Feb)	0.9928	-0.7%	In line with trend	16
FQ3 (Mar–May)	1.0391	+3.9%	+3.9% above trend	15
FQ4 (Jun–Aug)	1.0	+0.0%	In line with trend	0

How Spending Drives Revenue

Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

INCY COO ALGN VTRS BDX HOLX VRTX ELV